Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical Immunology (Orlando, Fla.)|May 22, 2013
Manipulating T cell-mediated pathology: targets and functions of monoclonal antibody immunotherapyAaron Martin, Roland M Tisch, Daniel R GettsFrontiers in Immunology|January 10, 2018
Type 1 Diabetes: A Chronic Anti-Self-Inflammatory ResponseMatthew Clark, Charles J Kroger, Roland M TischFrontiers in Immunology|May 9, 2012
Cumulative autoimmunity: T cell clones recognizing several self-epitopes exhibit enhanced pathogenicityRoland S Liblau, Hartmut Wekerle, Roland M TischFrontiers in Immunology|September 1, 2018
Therapies to Suppress β Cell Autoimmunity in Type 1 DiabetesCharles J Kroger, Matthew Clark, Qi Ke, et al.Frontiers in Immunology|March 8, 2021
Evolving Antibody Therapies for the Treatment of Type 1 DiabetesQi Ke, Charles J Kroger, Matthew Clark, et al.Frontiers in Immunology|February 19, 2021
The Role of T Cell Receptor Signaling in the Development of Type 1 DiabetesMatthew Clark, Charles J Kroger, Qi Ke, et al.Diabetes|August 28, 2003
Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetesSalah-Eddine Lamhamedi-Cherradi, Shijun Zheng, Roland M Tisch, et al.Advanced Healthcare Materials|July 28, 2018
Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31Naihan Chen, Charles J Kroger, Roland M Tisch, et al.European Journal of Immunology|January 9, 2003
The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptorsPablo A Silveira, Ellis Johnson, Harold D Chapman, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivityHongsheng Wang, Matilda W Nicholas, Kara L Conway, et al.Pageof 2